Two cases of sudden death [5] are reported in patients whose self-determined seizure management primarily relied on artisanal cannabis [6] therapies. Risks of morbidity [7], mortality and SUDEP in SDTC users need to be further studied. Providers should be aware of the absence of morbidity and mortality data for SDTC in patients with epilepsy [8] may only be due to a failure of reporting.
Links
[1] https://www.sciencedirect.com/science/article/pii/S2213323218301567
[2] http://rethinkpot.org/tags/epilepsy
[3] http://rethinkpot.org/tags/science-direct
[4] http://rethinkpot.org/tags/death
[5] https://www.sciencedirect.com/topics/medicine-and-dentistry/sudden-unexpected-death-in-epilepsy
[6] https://www.sciencedirect.com/topics/neuroscience/cannabis
[7] https://www.sciencedirect.com/topics/medicine-and-dentistry/morbidity
[8] https://www.sciencedirect.com/topics/neuroscience/epilepsy